27. November 2012CE Mark Indication for cobas 4800 HPV Test Supporting Its Use as a Primary Screen for Cervical CancerThe newly expanded indication for the cobas® 4800 HPV Test as a primary screen means Pap cytology is no longer required as a co- or pre-test in countries that accept a CE mark.more 25. July 2012Roche expands its blood screening portfolioNew solution improves safety of donated blood
more 05. July 2012Roche receives FDA approval for Cytomegalovirus viral load testFirst FDA-approved laboratory test for quantifying DNA of potentially deadly virus helps physicians manage organ transplant patients on antiviral therapy
more |